Researchers analyzed claims data for 266,586 U.S. adults diagnosed with COVID-19 between Jan. 1 and Oct. 31, 2020.
They found 14 percent of adults were diagnosed with at least one of 50 new health conditions within six months of their initial infection. This figure was 5 percent higher than a comparative group of U.S. adults who did have COVID-19, and 1.65 percent higher than adults with a viral lower respiratory tract infection.
New conditions COVID-19 survivors developed included chronic respiratory failure, heart rhythm problems, amnesia, diabetes, anxiety and fatigue.
“With almost 70 million individuals infected with SARS-CoV-2 worldwide and rising, the number of survivors with potential sequelae after COVID-19 will continue to grow,” researchers said. “To manage these patients effectively, understanding the incidence and natural history of these sequelae is important.”
To view the full study, click here.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
